查找临床试验
已按「阿尔茨海默病」检索，对应国际通用词 Alzheimer disease
共找到 121 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 22:14，每 5 分钟自动同步Transcranial Random Noise (tRNS) for BPSD in Alzheimer's Disease: A Double-blind Randomized Controlled Trial
China
年龄 45 Years – 84 Years
Anhui Medical University
PUMCH Dementia Longitudinal Cohort Study
China
年龄 18 Years – 不限
Peking Union Medical College Hospital
A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the Deposition of Aβ Plaques in the Brain of Participants With Normal Cognitive Function, MCI and AD Using [18F]Fluorbetazine Injection
China
年龄 40 Years – 不限
HTA Co., Ltd.
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease
China
年龄 50 Years – 85 Years
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease
China
年龄 50 Years – 85 Years
Jian Pei,MD
Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease
China
年龄 60 Years – 90 Years
Ruijin Hospital
Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging
China
年龄 45 Years – 90 Years
Huashan Hospital
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
United States、Argentina、Belgium、Brazil、Bulgaria 等 12 国
年龄 55 Years – 90 Years
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Combined Artificial Intelligence and Mobile Application for Remote Infant Motor Screening: Development and Validation
Taiwan
年龄 2 Months – 18 Months
National Taiwan University Hospital
An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease
China
年龄 45 Years – 85 Years
First Affiliated Hospital of Zhejiang University
Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD
China
年龄 50 Years – 不限
Sinotau Pharmaceutical Group
Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem Brain Tissue Tau Pathology in Individuals With HV and MCI or AD.
China
年龄 50 Years – 不限
JYAMS PET Research & Development Limited